Identification of a novel PROP1 mutation in a patient with combined pituitary hormone deficiency and enlarged pituitary

8Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Growth hormone deficiency (GHD) can be present from the neonatal period to adulthood and can be the result of congenital or acquired insults. In addition, GHD can be classified into two types: isolated growth hormone deficiency (IGHD) and combined pituitary hormone deficiency (CPHD). CPHD is a disorder characterized by impaired production of two or more anterior and/or posterior pituitary hormones. Many genes implicated in CPHD remain to be identified. Better genetic characterization will provide more information about the disorder and result in important genetic counselling because a number of patients with hypopituitarism represent familial cases. To date, PROP1 mutations represent the most common known genetic cause of CPHD both in sporadic and familial cases. We report a novel mutation in the PROP1 gene in an infant with CPHD and an enlarged pituitary gland. Close long-term follow-up will reveal other possible hormonal defects and pituitary involution.

Cite

CITATION STYLE

APA

Penta, L., Bizzarri, C., Panichi, M., Novelli, A., Lepri, F. R., Cappa, M., & Esposito, S. (2019). Identification of a novel PROP1 mutation in a patient with combined pituitary hormone deficiency and enlarged pituitary. International Journal of Molecular Sciences, 20(8). https://doi.org/10.3390/ijms20081875

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free